Found 5 matching trials
Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder PHASE2 This study tests the effects of an investigational antipsychotic drug (call...
Show More Location
Multiple Locations
Learn More & Join Trial
Multicenter, Open-label, Safety and Tolerability Study PHASE2 This will be a multicenter, 52 week, open label study to assess the safety ...
Show More Location
Otsuka Investigational Site
Learn More & Join Trial
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) PHASE3 To compare the effect of OPC-34712 (brexpiprazole) to the effect of placebo...
Show More Learn More & Join Trial
Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia PHASE1 To determine the pharmacokinetics, safety and tolerability of brexpiprazole...
Show More Location
Collaborative Neuro Science (CNS)
Learn More & Join Trial
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder PHASE2 This is a Double-blind study wherein patients with Major Depressive Disorde...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial